Kjell Olmarker
Corporate Officer/Principal presso University of Gothenburg
Profilo
Kjell Olmarker was the founder of PharmaSurgics In Sweden AB, founded in 2005, where he held the title of Director from 2005 to 2009, and Stayble Therapeutics AB, founded in 2015, where he held the title of Director.
Currently, Dr. Olmarker is a Professor at the University of Gothenburg.
Posizioni attive di Kjell Olmarker
Società | Posizione | Inizio |
---|---|---|
University of Gothenburg | Corporate Officer/Principal | - |
Precedenti posizioni note di Kjell Olmarker
Società | Posizione | Fine |
---|---|---|
STAYBLE THERAPEUTICS AB | Fondatore | - |
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
STAYBLE THERAPEUTICS AB | Health Technology |
Aziende private | 1 |
---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
- Borsa valori
- Insiders
- Kjell Olmarker